{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:09:06Z","timestamp":1778497746045,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,11]]},"DOI":"10.7759\/cureus.108634","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:11:28Z","timestamp":1778494288000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Primary Renal Ewing Sarcoma With Metastatic Presentation and Review of Multimodal Management"],"prefix":"10.7759","author":[{"given":"Keshav","family":"Paliwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananya","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj K","family":"Bamaniya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nachiket","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1186\/s12893-020-00948-9","article-title":"A rare entity of primary Ewing sarcoma in kidney","volume":"20","author":"Cheng L","year":"2020","unstructured":"Cheng L, Xu Y, Song H, Huang H, Zhuo D. A rare entity of primary Ewing sarcoma in kidney. BMC Surg. 2020, 20:280.","journal-title":"BMC Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2013.04.015","article-title":"Clinical and pathological features of primary neuroectodermal tumor\/Ewing sarcoma of the kidney","volume":"82","author":"Risi E","year":"2013","unstructured":"Risi E, Iacovelli R, Altavilla A, et al.. Clinical and pathological features of primary neuroectodermal tumor\/Ewing sarcoma of the kidney. Urology. 2013, 82:382-6. 10.1016\/j.urology.2013.04.015","journal-title":"Urology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020890","article-title":"Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone","volume":"348","author":"Grier HE","year":"2003","unstructured":"Grier HE, Krailo MD, Tarbell NJ, et al.. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003, 348:694-701. 10.1056\/NEJMoa020890","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2025.1512474","article-title":"Renal ewing sarcoma in a young female: a case report and review of targeted therapy","volume":"12","author":"Wang P","year":"2025","unstructured":"Wang P, Wang M, Zhan J, Hu X, Meng X. Renal ewing sarcoma in a young female: a case report and review of targeted therapy. Front Surg. 2025, 12:1512474. 10.3389\/fsurg.2025.1512474","journal-title":"Front Surg"},{"key":"ref5","article-title":"Peripheral neuroectodermal tumors","volume":"2","author":"Seemayer TA","year":"1975","unstructured":"Seemayer TA, Thelmo WL, Bolande RP, Wiglesworth FW. Peripheral neuroectodermal tumors. Perspect Pediatr Pathol. 1975, 2:151-72.","journal-title":"Perspect Pediatr Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.11.032","article-title":"Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial","volume":"181","author":"Thompson IM","year":"2009","unstructured":"Thompson IM, Tangen CM, Paradelo J, et al.. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol. 2009, 181:956-62. 10.1016\/j.juro.2008.11.032","journal-title":"J Urol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200102000-00001","article-title":"Primary malignant neuroepithelial tumors of the kidney: a clinicopathologic analysis of 146 adult and pediatric cases from the National Wilms' Tumor Study Group Pathology Center","volume":"25","author":"Parham DM","year":"2001","unstructured":"Parham DM, Roloson GJ, Feely M, Green DM, Bridge JA, Beckwith JB. Primary malignant neuroepithelial tumors of the kidney: a clinicopathologic analysis of 146 adult and pediatric cases from the National Wilms' Tumor Study Group Pathology Center. Am J Surg Pathol. 2001, 25:133-46. 10.1097\/00000478-200102000-00001","journal-title":"Am J Surg Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.5898","article-title":"Association between non-melanoma and melanoma skin cancer rates, vitamin D and latitude","volume":"13","author":"Rivas M","year":"2017","unstructured":"Rivas M, Rojas E, Calaf GM, Barber\u00e1n M, Liberman C, De Paula Correa M. Association between non-melanoma and melanoma skin cancer rates, vitamin D and latitude. Oncol Lett. 2017, 13:3787-92. 10.3892\/ol.2017.5898","journal-title":"Oncol Lett"},{"key":"ref9","article-title":"Detection of the (11;22)(q24;q12) translocation","volume":"143","author":"Downing JR","year":"1993","unstructured":"Downing JR, Head DR, Parham DM, et al.. Detection of the (11;22)(q24;q12) translocation. Am J Pathol. 1993, 143:1294-300.","journal-title":"Am J Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.045286","article-title":"Significant benefit of multimodal imaging: PET\/CT compared with PET alone in staging and follow-up of patients with Ewing tumors","volume":"48","author":"Gerth HU","year":"2007","unstructured":"Gerth HU, Juergens KU, Dirksen U, Gerss J, Schober O, Franzius C. Significant benefit of multimodal imaging: PET\/CT compared with PET alone in staging and follow-up of patients with Ewing tumors. J Nucl Med. 2007, 48:1932-9. 10.2967\/jnumed.107.045286","journal-title":"J Nucl Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/01.mnm.0000186608.12895.69","article-title":"Impact of FDG PET for staging of Ewing sarcomas","volume":"27","author":"Gy\u00f6rke T","year":"2006","unstructured":"Gy\u00f6rke T, Zajic T, Lange A, Sch\u00e4fer O, Moser E, Mak\u00f3 E, Brink I. Impact of FDG PET for staging of Ewing sarcomas. Nucl Med Commun. 2006, 27:17-24. 10.1097\/01.mnm.0000186608.12895.69","journal-title":"Nucl Med Commun"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/2045-3329-2-12","article-title":"Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing's and other small round cell sarcomas","volume":"2","author":"Whelan J","year":"2012","unstructured":"Whelan J, Khan A, Sharma A, et al.. Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing's and other small round cell sarcomas. Clin Sarcoma Res. 2012, 2:12. 10.1186\/2045-3329-2-12","journal-title":"Clin Sarcoma Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31933","article-title":"Reply to Perceptions of future health and cancer risk in adult survivors of childhood cancer: Implications for engagement in follow-up care","volume":"125","author":"Gibson TM","year":"2019","unstructured":"Gibson TM, Armstrong GT, Robison LL. Reply to Perceptions of future health and cancer risk in adult survivors of childhood cancer: Implications for engagement in follow-up care. Cancer. 2019, 125:1009-10. 10.1002\/cncr.31933","journal-title":"Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-0622","article-title":"Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations","volume":"4","author":"Tirode F","year":"2014","unstructured":"Tirode F, Surdez D, Ma X, et al.. Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer Discov. 2014, 4:1342-53. 10.1158\/2159-8290.CD-14-0622","journal-title":"Cancer Discov"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000000642","article-title":"In-vitro antitumor activity of new quaternary phosphonium salts, derivatives of 3-hydroxypyridine","volume":"29","author":"Iksanova AG","year":"2018","unstructured":"Iksanova AG, Gabbasova RR, Kupriyanova TV, et al.. In-vitro antitumor activity of new quaternary phosphonium salts, derivatives of 3-hydroxypyridine. Anticancer Drugs. 2018, 29:682-90. 10.1097\/CAD.0000000000000642","journal-title":"Anticancer Drugs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/487410-a-case-of-primary-renal-ewing-sarcoma-with-metastatic-presentation-and-review-of-multimodal-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:11:30Z","timestamp":1778494290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/487410-a-case-of-primary-renal-ewing-sarcoma-with-metastatic-presentation-and-review-of-multimodal-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.108634","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,11]]}}}